USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$40.18 USD
+0.36 (0.90%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $40.19 +0.01 (0.02%) 5:06 PM ET
5-Strong Sell of 5 5
A Value D Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
USNA 40.18 +0.36(0.90%)
Will USNA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USNA
Xencor (XNCR) Surges 10.5%: Is This an Indication of Further Gains?
USANA Health Sciences (USNA) Misses Q2 Earnings and Revenue Estimates
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USNA vs. ZTS: Which Stock Is the Better Value Option?
USNA or ZTS: Which Is the Better Value Stock Right Now?
USNA vs. ZTS: Which Stock Is the Better Value Option?
Other News for USNA
USANA-Sponsored Olympic and Paralympic Athletes Take Home 99 Combined Medals
PBJ: Consumer Staples Dashboard For September
USANA Executive Chairman Kevin Guest Celebrates Entrepreneurs in Today's Business World
USANA Launches New, Innovative Skincare and Protein Products Resurfacing Serum and Whey Protein Isolate up the game for USANA
Usana management to meet with DA Davidson